These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 22703285)

  • 1. SOXs in human prostate cancer: implication as progression and prognosis factors.
    Zhong WD; Qin GQ; Dai QS; Han ZD; Chen SM; Ling XH; Fu X; Cai C; Chen JH; Chen XB; Lin ZY; Deng YH; Wu SL; He HC; Wu CL
    BMC Cancer; 2012 Jun; 12():248. PubMed ID: 22703285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of SOCSs in human prostate cancer and their association in prognosis.
    Zhu JG; Dai QS; Han ZD; He HC; Mo RJ; Chen G; Chen YF; Wu YD; Yang SB; Jiang FN; Chen WH; Sun ZL; Zhong WD
    Mol Cell Biochem; 2013 Sep; 381(1-2):51-9. PubMed ID: 23666742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenicity of the transcription factor SOX8 in hepatocellular carcinoma.
    Zhang S; Zhu C; Zhu L; Liu H; Liu S; Zhao N; Wu J; Huang X; Zhang Y; Jin J; Ji T; Ding X
    Med Oncol; 2014 Apr; 31(4):918. PubMed ID: 24643625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of microRNA-21 expression with clinicopathological characteristics and the risk of progression in advanced prostate cancer patients receiving androgen deprivation therapy.
    Guan Y; Wu Y; Liu Y; Ni J; Nong S
    Prostate; 2016 Aug; 76(11):986-93. PubMed ID: 27040772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression of SOX7 in ovarian cancer: a novel tumor suppressor through the Wnt/β-catenin signaling pathway.
    Liu H; Yan ZQ; Li B; Yin SY; Sun Q; Kou JJ; Ye D; Ferns K; Liu HY; Liu SL
    J Ovarian Res; 2014 Sep; 7():87. PubMed ID: 25297608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced expression of centromere protein F predicts clinical progression and prognosis in patients with prostate cancer.
    Zhuo YJ; Xi M; Wan YP; Hua W; Liu YL; Wan S; Zhou YL; Luo HW; Wu SL; Zhong WD; Wu CL
    Int J Mol Med; 2015 Apr; 35(4):966-72. PubMed ID: 25647485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer.
    Xie JJ; Zhuo YJ; Zheng Y; Mo RJ; Liu ZZ; Li BW; Cai ZD; Zhu XJ; Liang YX; He HC; Zhong WD
    Int Urol Nephrol; 2017 May; 49(5):817-823. PubMed ID: 28213802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined overexpression of HIVEP3 and SOX9 predicts unfavorable biochemical recurrence-free survival in patients with prostate cancer.
    Qin GQ; He HC; Han ZD; Liang YX; Yang SB; Huang YQ; Zhou L; Fu H; Li JX; Jiang FN; Zhong WD
    Onco Targets Ther; 2014; 7():137-46. PubMed ID: 24493929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of SOX7 is correlated with poor prognosis in lung adenocarcinoma patients.
    Li B; Ge Z; Song S; Zhang S; Yan H; Huang B; Zhang Y
    Pathol Oncol Res; 2012 Oct; 18(4):1039-45. PubMed ID: 22777918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
    Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
    Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
    Zhang X; Wang Y; Ning Y
    Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinesin Family Member 11 mRNA Expression Predicts Prostate Cancer Aggressiveness.
    Piao XM; Byun YJ; Jeong P; Ha YS; Yoo ES; Yun SJ; Kim WJ
    Clin Genitourin Cancer; 2017 Aug; 15(4):450-454. PubMed ID: 27842896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-30c serves as an independent biochemical recurrence predictor and potential tumor suppressor for prostate cancer.
    Ling XH; Han ZD; Xia D; He HC; Jiang FN; Lin ZY; Fu X; Deng YH; Dai QS; Cai C; Chen JH; Liang YX; Zhong WD; Wu CL
    Mol Biol Rep; 2014 May; 41(5):2779-88. PubMed ID: 24452717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of serine protease inhibitor family G1 (SERPING1) in prostate cancer can help distinguish high-risk prostate cancer and predicts malignant progression.
    Peng S; Du T; Wu W; Chen X; Lai Y; Zhu D; Wang Q; Ma X; Lin C; Li Z; Guo Z; Huang H
    Urol Oncol; 2018 Aug; 36(8):366.e1-366.e9. PubMed ID: 29903461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.
    Sun X; Yang Z; Zhang Y; He J; Wang F; Su P; Han J; Song Z; Fei Y
    Int J Clin Exp Pathol; 2015; 8(7):8394-401. PubMed ID: 26339409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX15 and SOX7 differentially regulate the myogenic program in P19 cells.
    Savage J; Conley AJ; Blais A; Skerjanc IS
    Stem Cells; 2009 Jun; 27(6):1231-43. PubMed ID: 19489079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced expression of IMPDH2 promotes metastasis and advanced tumor progression in patients with prostate cancer.
    Zhou L; Xia D; Zhu J; Chen Y; Chen G; Mo R; Zeng Y; Dai Q; He H; Liang Y; Jiang F; Zhong W
    Clin Transl Oncol; 2014 Oct; 16(10):906-13. PubMed ID: 24659377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients.
    Avgeris M; Stravodimos K; Fragoulis EG; Scorilas A
    Br J Cancer; 2013 Jun; 108(12):2573-81. PubMed ID: 23703249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
    Tilli TM; Thuler LC; Matos AR; Coutinho-Camillo CM; Soares FA; da Silva EA; Neves AF; Goulart LR; Gimba ER
    Exp Mol Pathol; 2012 Feb; 92(1):13-9. PubMed ID: 21963599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Pleomorphic Adenoma Gene-Like 2 Is a Novel Poor Prognostic Marker of Prostate Cancer.
    Guo J; Wang M; Wang Z; Liu X
    PLoS One; 2016; 11(8):e0158667. PubMed ID: 27537362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.